Skip to main content
Year archive

ERYTECH Pharma S.A. — 2020 filings

All 57 regulatory filings released by ERYTECH Pharma S.A. (ERYP) in 2020, sourced directly from the official regulator.

57 Filings
2020 Period
2020 filings (57)
Filing Released Lang
ERYTECH finalise le recrutement des patients pour son étude de Phase 3 TRYbeCA-1 dans le traitement en seconde ligne du cancer du pancréas
Legal Proceedings Report
2020-12-14 French
ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer
Regulatory Filings
2020-12-14 English
ERYTECH tiendra une présentation lors de la conférence JMP Securities Hematology
Investor Presentation
2020-12-10 French
ERYTECH to Present at the JMP Securities Hematology Summit
Report Publication Announcement
2020-12-10 English
Monthly information related to total number of voting rights and shares composing the share capital – November 30, 2020
Share Issue/Capital Change
2020-12-10 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 novembre 2020
Share Issue/Capital Change
2020-12-10 French
ERYTECH annonce les résultats positifs de l’étude de phase 2 dans la leucémie aiguë lymphoblastique avec eryaspase lors du congrès annuel de l’ASH 2020
Earnings Release FY 2020
2020-12-07 French
ERYTECH Announces Positive Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Presented at the American Society of Hematology Annual Meeting
Earnings Release FY 2020
2020-12-07 English
ERYTECH tiendra un webcast pour commenter les résultats de l’étude de phase 2 dans la leucémie aiguë lymphoblastique avec eryaspase présentés lors de l’ASH 2020
Report Publication Announcement
2020-12-03 French
ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting
Regulatory Filings
2020-12-03 English
ERYTECH présentera à l’occasion de la Jefferies Virtual Healthcare Conference
Report Publication Announcement
2020-11-12 French
ERYTECH to Present at Jefferies Virtual Healthcare Conference
Report Publication Announcement
2020-11-12 English
ERYTECH fait le point sur ses activités et publie ses résultats du troisième trimestre 2020
Earnings Release 9M 2020
2020-11-05 French
ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2020
Earnings Release 9M 2020
2020-11-05 English
ERYTECH Announces Abstract with Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Selected for Oral Presentation at the American Society of Hematology 2020 Annual Meeting
Investor Presentation
2020-11-05 English
ERYTECH présentera les résultats de l’étude de phase 2 dans la leucémie aiguë lymphoblastique avec eryaspase lors du congrès annuel de l’ASH 2020
Earnings Release FY 2020
2020-11-05 French
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 Octobre 2020
Declaration of Voting Results & Voting Rights Announcements
2020-11-04 French
Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2020.
Declaration of Voting Results & Voting Rights Announcements
2020-11-04 English
ERYTECH obtient un financement non dilutif de 10 millions d’euros garanti par l’État français
Capital/Financing Update
2020-11-02 French
ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Government
Capital/Financing Update
2020-11-02 English
ERYTECH tiendra un webcast le 6 novembre 2020 à l’occasion de ses résultats du troisième trimestre 2020
Report Publication Announcement
2020-10-29 French
ERYTECH to Host Third Quarter 2020 Conference Call and Business Update on November 6, 2020
Call Transcript
2020-10-29 English
ERYTECH nomme Stewart Craig en qualité de Directeur Technique (CTO)
Board/Management Information
2020-10-26 French
ERYTECH Appoints Stewart Craig as Chief Technical Officer
Board/Management Information
2020-10-26 English
RAPPORT FINANCIER SEMESTRIEL - 30 JUIN 2020
Interim / Quarterly Report H2 2020
2020-10-13 French
Monthly information related to total number of voting rights and shares composing the share capital - September 30, 2020
Regulatory Filings
2020-10-12 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 Septembre 2020
Share Issue/Capital Change
2020-10-12 French
ERYTECH fait le point sur ses activités et publie ses résultats semestriels 2020
Interim / Quarterly Report H2 2020
2020-09-21 French
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020
Interim / Quarterly Report H2 2020
2020-09-21 English
ERYTECH complète son dispositif de financement avec la mise en place d’un programme At the Market sur le Nasdaq avec Cowen
Share Issue/Capital Change
2020-09-21 French
ERYTECH establishes a financing facility with the implementation of an at-the-market program on Nasdaq with Cowen
Share Issue/Capital Change
2020-09-21 English
ERYTECH tiendra un webcast le 22 septembre 2020 à l’occasion de ses résultats semestriels 2020
Earnings Release H2 2020
2020-09-16 French
ERYTECH to Host on September 22, 2020 Second Quarter 2020 Conference Call and Business Update
Report Publication Announcement
2020-09-16 English
ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment
Report Publication Announcement
2020-09-14 English
ERYTECH annonce l'organisation d'un événement avec un leader d’opinion à l’approche de la finalisation de la Phase 3 de l’étude clinique TRYbeCA-1 dans le traitement en seconde ligne du cancer du panc
Earnings Release FY 2020
2020-09-14 French
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 Août 2020
Declaration of Voting Results & Voting Rights Announcements
2020-09-14 French
Monthly information related to total number of voting rights and shares composing the share capital – August 31, 2020
Declaration of Voting Results & Voting Rights Announcements
2020-09-14 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 Juillet 2020
Declaration of Voting Results & Voting Rights Announcements
2020-08-06 French
Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2020
Declaration of Voting Results & Voting Rights Announcements
2020-08-06 English
Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2020
Declaration of Voting Results & Voting Rights Announcements
2020-07-10 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 Juin 2020
Declaration of Voting Results & Voting Rights Announcements
2020-07-10 French
ERYTECH Reports Voting Results from its Annual General Meeting Held on June 26, 2020
AGM Information
2020-06-26 English
ERYTECH présente le résultat des votes de l’Assemblée Générale Mixte du 26 juin 2020
AGM Information
2020-06-26 French
ERYTECH étend son horizon de trésorerie par la mise en place d’un financement en obligations convertibles
Capital/Financing Update
2020-06-25 French
ERYTECH extends its cash horizon by implementing a convertible bond financing
Capital/Financing Update
2020-06-25 English
Erytech’s Combined Shareholders’ Meeting
AGM Information
2020-05-26 English
ERYTECH Provides Business Update and Reports Cash Balance at End of Q1 2020
Earnings Release Q1 2020
2020-05-06 English
ERYTECH to Present at Cowen and Company 40th Annual Health Care Conference
Report Publication Announcement
2020-02-26 English
ERYTECH annonce sa participation à la 40ème conférence Santé de Cowen
Report Publication Announcement
2020-02-26 French
ERYTECH annonce la signature d’un partenariat stratégique d'approvisionnement avec le service de don du sang de la Croix-Rouge allemande
Regulatory Filings
2020-02-20 French
ERYTECH Enters Into Strategic Supply Partnership with the German Red Cross Blood Donor Service
Regulatory Filings
2020-02-20 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 Janvier 2020
Declaration of Voting Results & Voting Rights Announcements
2020-02-04 French
Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2020
Declaration of Voting Results & Voting Rights Announcements
2020-02-04 English
ERYTECH présente un poster sur TRYbeCA1 lors du symposium ASCO 2020
Regulatory Filings
2020-01-24 French
ERYTECH Announces a Poster Presentation for TRYbeCA1 at the ASCO 2020
Regulatory Filings
2020-01-24 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 Décembre 2019
Declaration of Voting Results & Voting Rights Announcements
2020-01-10 French
Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2019
Declaration of Voting Results & Voting Rights Announcements
2020-01-10 English